S&P 500   3,120.12 (-0.01%)
DOW   28,010.63 (+0.02%)
QQQ   202.65 (-0.13%)
CGC   14.75 (-3.78%)
BABA   186.69 (+0.65%)
GE   11.37 (-1.30%)
T   39.32 (-0.48%)
ACB   2.46 (-9.91%)
F   8.94 (-0.11%)
PRI   130.35 (-0.21%)
BAC   32.89 (-0.12%)
DIS   148.69 (+2.78%)
S&P 500   3,120.12 (-0.01%)
DOW   28,010.63 (+0.02%)
QQQ   202.65 (-0.13%)
CGC   14.75 (-3.78%)
BABA   186.69 (+0.65%)
GE   11.37 (-1.30%)
T   39.32 (-0.48%)
ACB   2.46 (-9.91%)
F   8.94 (-0.11%)
PRI   130.35 (-0.21%)
BAC   32.89 (-0.12%)
DIS   148.69 (+2.78%)
S&P 500   3,120.12 (-0.01%)
DOW   28,010.63 (+0.02%)
QQQ   202.65 (-0.13%)
CGC   14.75 (-3.78%)
BABA   186.69 (+0.65%)
GE   11.37 (-1.30%)
T   39.32 (-0.48%)
ACB   2.46 (-9.91%)
F   8.94 (-0.11%)
PRI   130.35 (-0.21%)
BAC   32.89 (-0.12%)
DIS   148.69 (+2.78%)
S&P 500   3,120.12 (-0.01%)
DOW   28,010.63 (+0.02%)
QQQ   202.65 (-0.13%)
CGC   14.75 (-3.78%)
BABA   186.69 (+0.65%)
GE   11.37 (-1.30%)
T   39.32 (-0.48%)
ACB   2.46 (-9.91%)
F   8.94 (-0.11%)
PRI   130.35 (-0.21%)
BAC   32.89 (-0.12%)
DIS   148.69 (+2.78%)
Log in

ChemoCentryx Price Target & Analyst Ratings (NASDAQ:CCXI)

$8.40
-0.44 (-4.98 %)
(As of 11/18/2019 11:34 AM ET)
Today's Range
$8.39
Now: $8.40
$8.86
50-Day Range
$6.53
MA: $8.03
$9.96
52-Week Range
$6.16
Now: $8.40
$14.98
Volume13,730 shs
Average Volume404,735 shs
Market Capitalization$487.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14

Analyst Ratings

ChemoCentryx (NASDAQ:CCXI) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for ChemoCentryx in the last 12 months. Their average twelve-month price target is $18.33, suggesting that the stock has a possible upside of 118.25%. The high price target for CCXI is $23.00 and the low price target for CCXI is $14.00. There are currently 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.143.143.172.86
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.33$18.33$19.20$20.33
Price Target Upside: 118.25% upside130.90% upside114.29% upside51.63% upside

ChemoCentryx (NASDAQ:CCXI) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ChemoCentryx (NASDAQ:CCXI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/15/2019JPMorgan Chase & Co.Reiterated RatingBuyLow
6/6/2019Raymond JamesLower Price TargetStrong-Buy$24.00 ➝ $17.00High
6/6/2019Canaccord GenuityLower Price TargetBuy$20.00 ➝ $14.00High
5/7/2019HC WainwrightReiterated RatingBuy$23.00High
3/27/2019B. RileyUpgradeNeutral ➝ Buy$12.50 ➝ $22.00High
2/14/2019Svb LeerinkReiterated RatingOutperformN/A
2/11/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$20.00High
5/10/2018CowenReiterated RatingHoldMedium
(Data available from 11/18/2017 forward)
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Featured Article: Support Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel